The US Supreme Court convened on 27 April 2026, to deliberate a significant case that could reshape the landscape for lawsuits against pesticide manufacturers, particularly concerning glyphosate, a chemical linked to cancer. The proceedings in *Monsanto v. Durnell* raised critical questions about the balance between federal regulatory authority and state-level consumer rights, drawing attention from both legal experts and activists.
Glyphosate Under Scrutiny
Glyphosate, the active ingredient in the widely used weedkiller Roundup, has been at the centre of controversy due to its alleged health risks, including its classification as a probable human carcinogen by the World Health Organization in 2015. Bayer, which acquired Monsanto in 2018, has faced more than 100,000 lawsuits from individuals claiming that exposure to glyphosate led to their diagnosis of non-Hodgkin lymphoma. The company has spent billions in settlements and legal costs as it fights to maintain its product’s reputation.
The current case hinges on whether the federal law, specifically the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), preempts state laws that allow consumers to file lawsuits for failure to warn about potential cancer risks associated with glyphosate. Bayer maintains that, according to FIFRA, it cannot be held liable for failing to include warnings on product labels unless the Environmental Protection Agency (EPA) has designated such warnings as necessary. The EPA’s stance is that glyphosate is “unlikely” to cause cancer, a position Bayer argues should protect it from state-level legal challenges.
Legal Arguments and Implications
During the hearing, Paul Clement, representing Monsanto, contended that FIFRA’s provisions are unequivocal in prohibiting pesticide manufacturers from altering safety labels without EPA approval. He emphasised that allowing state-level lawsuits could disrupt the uniformity intended by Congress and impose excessive liability on companies that rely on federal regulatory standards.
Conversely, Ashley Keller, arguing against Monsanto, challenged the interpretation of FIFRA, asserting that it does not provide the broad immunity claimed by the company. Keller pointed out the EPA’s failure to update its glyphosate review as mandated by law, arguing that the agency’s oversight has significant gaps. He highlighted that the Ninth Circuit Court of Appeals had previously vacated the EPA’s findings on glyphosate’s safety due to procedural oversights and a disregard for crucial studies on cancer risk.
The justices engaged in an active dialogue, probing issues such as how new scientific evidence of harm should influence labelling and the fairness of penalising companies for prior EPA-approved labels. Notably, the court’s three liberal justices appeared sceptical of Monsanto’s arguments, leaving the outcome uncertain.
Public Response and Activism
Outside the Supreme Court, demonstrators affiliated with the Maha movement rallied in protest, expressing their concerns over Monsanto’s past practices and the Trump administration’s support for the company. Protesters chanted slogans like “people over poison” and carried signs demanding accountability from pesticide manufacturers. Zen Honeycutt, founder of Moms Across America, stated, “We will not stand for being poisoned… These companies must have accountability and it starts today.”
Among the demonstrators was Alexandra Munoz, an independent toxicologist, who asserted the carcinogenic nature of glyphosate based on extensive literature reviews. Democratic Representative Chellie Pingree from Maine joined the protest, highlighting the bipartisan concern regarding pesticide safety.
As the Supreme Court proceedings unfold, the House of Representatives is concurrently considering the Farm Bill, which, if amended, could remove protections for chemical manufacturers against lawsuits. This legislative context adds an additional layer of complexity to the court’s decision.
Why it Matters
The outcome of *Monsanto v. Durnell* could have far-reaching consequences for consumer rights and public health. A ruling in favour of Monsanto would significantly restrict the ability of individuals to seek redress for potential health hazards associated with pesticides, setting a precedent that may inhibit state-level regulatory actions. Conversely, a decision supporting consumer lawsuits could empower individuals and state authorities to hold corporations accountable for product safety, potentially reshaping the agricultural landscape and influencing future pesticide regulations. As public awareness of health risks associated with chemical exposures grows, the implications of this case resonate beyond the courtroom, affecting food safety, environmental policy, and consumer rights across the nation.